Mike Nohaile is the Chief Executive Officer at Prellis Biologics. Prior to this, he was a partner at Flagship Pioneering and Chief Scientific Officer at Generate Biomedicines. Earlier in his career, he served as Senior Vice President of Strategy, Commercialization & Innovation at Amgen. Prior to Amgen, he served as the head and general manager of the Molecular Diagnostics Business Unit at Novartis. Mike began his career at McKinsey & Company as partner in the New Jersey office, where he worked extensively in the healthcare area with a particular focus on diagnostics, devices and pharmaceuticals. He has a doctorate in molecular and cell biology from University of California, Berkeley, and he was a postdoctoral fellow at MIT in the Department of Biology.